Form 4 for RCKT ROCKET PHARMACEUTICALS, INC.
Accepted 2025-05-22 00:00:00 ET · period of report 2025-05-20 · accession 0001140361-25-020160 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-22 | 2025-05-20 | RCKT | Shah Gaurav | CEO, Dir | S - Sale | $6.45 | -2,253 | 786.8K | -0.3% | -$14.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-20 | S | D | 2,253 | $6.45 | 786,806 | D | — | — | (F1) Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. |